BAC
50
-3
PCG
93
2
KMX
58
3
EXR
57
-2
COST
58
-2
INTU
51
2
CMCSA
48
2
MS
74
-2
JPM
63
-4
IFF
53
2
STI
47
-12
DAL
80
-4
COP
56
2
JWN
40
-2
AVGO
20
-5
SYK
64
-4
SRE
63
-3
CVS
48
3
HPE
55
11
ALLE
37
5
BAC
50
-3
PCG
93
2
KMX
58
3
EXR
57
-2
COST
58
-2
INTU
51
2
CMCSA
48
2
MS
74
-2
JPM
63
-4
IFF
53
2
STI
47
-12
DAL
80
-4
COP
56
2
JWN
40
-2
AVGO
20
-5
SYK
64
-4
SRE
63
-3
CVS
48
3
HPE
55
11
ALLE
37
5
Financhill
Back

Kiniksa Pharmaceuticals International PLC Vs. Stoke Therapeutics Industry Stock Comparison

Sell
41

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
21.16
Seasonality Move:
39.39%
Sell
20

STOK
Stoke Therapeutics

Last Price:
11.31
Seasonality Move:
-1.15%
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA) is a Sell

Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?

  • The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.21. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • KNSA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Stoke Therapeutics (STOK) is a Sell

Is Stoke Therapeutics a Buy, Sell or Hold?

  • The current Stoke Therapeutics [STOK] share price is $11.31. The Score for STOK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • STOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KNSA Stock Price Chart

What is Kiniksa Pharmaceuticals International PLC's stock price today?

  • The Kiniksa Pharmaceuticals International PLC share price today is $21.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing slight buying pressure.

STOK Stock Price Chart

What is Stoke Therapeutics's stock price today?

  • The Stoke Therapeutics share price today is $11.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.

KNSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 99094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.52 - 25.92) Sell
Bollinger Bands (100): (22.05 - 26.55) Sell

STOK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -45377 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.99 - 13.47) Sell
Bollinger Bands (100): (12.44 - 14.7) Sell

KNSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.91 Sell
20-day SMA: 23.05 Sell
50-day SMA: 24.39 Sell
200-day SMA: 21.77 Sell
8-day EMA: 21.74 Sell
20-day EMA: 22.79 Sell
50-day EMA: 23.8 Sell
200-day EMA: 22.04 Sell

STOK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.76 Sell
20-day SMA: 12.75 Sell
50-day SMA: 12.87 Sell
200-day SMA: 12.28 Sell
8-day EMA: 12.34 Sell
20-day EMA: 12.67 Sell
50-day EMA: 12.95 Sell
200-day EMA: 12.11 Sell

Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.89 per share.

Stoke Therapeutics Earnings Growth & STOK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.47 per share.

Kiniksa Pharmaceuticals International PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Stoke Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):